Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Crash on Highway 1 Near Willow Creek Bridge


Car Slides Off Cliff in Fatal Big Sur Accident

Big Sur, CA (April 5, 2020) – A man was killed in a solo-vehicle crash on Big Sur. The fatal accident occurred on the morning of April 5 on Highway 1. 

A 32-year-old man from Seaside was driving a Toyota Tundra northbound on Highway 1, near Willow Creek Bridge, when he lost control. His vehicle slid off a cliff and landed 400 feet down. 

The man died at the accident scene. It was rainy and windy at the time of the crash.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Big Sur

#93920


March 31, 2020

1 Killed in Crash on Interstate 15 Near Glen Helen Parkway

Pedestrian Hit by Car in Fatal San Bernardino Accident...


October 31, 2019

1 Injured in Train Crash on 9th Street

Train, Car Collide in National City Accident...


December 17, 2019

Child Injured in Crash at Woodland Parkway and Rock Springs Road

Boy Hit by Car in San Marcos Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.